Objective: To assess the value of endometrial thickness as a marker of endometrial abnormality risk during hormone therapy (HT) and to study the correlation between abnormal bleeding and abnormal endometrial histology in patients with thick endometrium. Design: Prospective multicenter study. Setting: University and general hospitals outpatient centers. Patient(s): Postmenopausal women (702) on HT. Intervention(s): Biendometrial thickness was measured by transvaginal sonography (TVS) between day 5 and day 10 after the last P intake and, when present, after the end of the menstrual-like bleeding. Main Outcome Measure(s): Hysteroscopy and biopsy were performed within 5 days from TVS on all patients with an endometrial thickness 4.5 mm (precision scale 0.5 mm). Result(s): Endometrial thickness 4.5 mm was observed in 20.5% of patients. One hundred sixteen hysteroscopies and biopsies were performed. Hyperplasia, polyps, and endocavitary fibroids were detected in 15%, 24%, and 8% of cases, respectively. The positive predictive value of TVS examination was 47%. Endometrial thickness was the only variable significantly and independently associated with histologic abnormalities and endocavitary fibroids. Abnormal bleeding occurred in 17.1% of patients. Among 17 patients detected with thick endometrium and hyperplasia, 8 cases showed abnormal bleeding. Conclusion(s): Sonographic endometrial thickness of 4.5 mm provides a sensitive tool to select HT patients who might benefit from hysteroscopy and biopsy. Abnormal bleeding is not a sensitive sign of hyperplasia in patients with thick endometrium.
ENDOMETRIAL EVALUATION WITH TRANSVAGINAL ULTRASOUND DURING HORMONE THERAPY: A PROSPECTIVE MULTICENTER STUDY / A. BECORPI; G. SCARSELLI; U. OMODEI; E. FERRAZZI; F. RAMAZZOTTO; E. GRIMALDI; D. SPAGNOLO; L. SPAGNOLO; W. TORRI. - In: FERTILITY AND STERILITY. - ISSN 0015-0282. - ELETTRONICO. - 81:(2004), pp. 1632-1637.
ENDOMETRIAL EVALUATION WITH TRANSVAGINAL ULTRASOUND DURING HORMONE THERAPY: A PROSPECTIVE MULTICENTER STUDY
SCARSELLI, GIANFRANCO;
2004
Abstract
Objective: To assess the value of endometrial thickness as a marker of endometrial abnormality risk during hormone therapy (HT) and to study the correlation between abnormal bleeding and abnormal endometrial histology in patients with thick endometrium. Design: Prospective multicenter study. Setting: University and general hospitals outpatient centers. Patient(s): Postmenopausal women (702) on HT. Intervention(s): Biendometrial thickness was measured by transvaginal sonography (TVS) between day 5 and day 10 after the last P intake and, when present, after the end of the menstrual-like bleeding. Main Outcome Measure(s): Hysteroscopy and biopsy were performed within 5 days from TVS on all patients with an endometrial thickness 4.5 mm (precision scale 0.5 mm). Result(s): Endometrial thickness 4.5 mm was observed in 20.5% of patients. One hundred sixteen hysteroscopies and biopsies were performed. Hyperplasia, polyps, and endocavitary fibroids were detected in 15%, 24%, and 8% of cases, respectively. The positive predictive value of TVS examination was 47%. Endometrial thickness was the only variable significantly and independently associated with histologic abnormalities and endocavitary fibroids. Abnormal bleeding occurred in 17.1% of patients. Among 17 patients detected with thick endometrium and hyperplasia, 8 cases showed abnormal bleeding. Conclusion(s): Sonographic endometrial thickness of 4.5 mm provides a sensitive tool to select HT patients who might benefit from hysteroscopy and biopsy. Abnormal bleeding is not a sensitive sign of hyperplasia in patients with thick endometrium.File | Dimensione | Formato | |
---|---|---|---|
becorpi.pdf
Accesso chiuso
Tipologia:
Versione finale referata (Postprint, Accepted manuscript)
Licenza:
Tutti i diritti riservati
Dimensione
235.47 kB
Formato
Adobe PDF
|
235.47 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.